Delivery Order SPE2DR25D2106-SPE2DR26F1FWF
Award Date 12/2/25
Potential Completion Date 12/3/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,785.42 to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units) on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio. The product will be delivered to the company's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,074.77 to AmerisourceBergen Drug Corp for the supply of Xeljanz 5 mg tablets (60-count units). This non-competitive delivery order, issued on April 22, 2025, with completion by April 23, 2025, represents a firm fixed-price transaction under DLA's pharmaceutical procurement framework. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,533.49 to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed price delivery order was competitively awarded without any set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction within DLA's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Xeljanz XR 11 mg tablets (30-count units) with a ceiling value of $18,899.73. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by December 8, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $73,540.08 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) with a completion deadline of April 30, 2025. This competitively awarded, firm fixed-price contract was issued on April 29, 2025, with no set-aside designation. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,940.08 to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units) with completion targeted for October 20, 2025. This firm fixed-price, competitively awarded contract contains no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a specific pharmaceutical product delivery under AmerisourceBergen's existing contract vehicle with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,169.80 to supply Xeljanz XR 11 mg tablets (30-count units) under a firm fixed-price contract. The award, made on November 24, 2025, with an ultimate completion date of November 25, 2025, is a non-set-aside competitively awarded delivery order. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $8,320.29 to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units) on August 21, 2025, with completion scheduled for August 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xeljanz XR 11 mg tablets (30-count units) valued at $8,107.66 under a firm fixed-price contract type. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical supplies to federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $11,265.58 to AmerisourceBergen Drug Corp for the supply of Xeljanz XR 11 mg tablets (30-count units) under a firm fixed price contract type. The award, issued on November 4, 2025, with an ultimate completion date of November 5, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply...